Herpes zoster (HZ) brings a significant economic burden. The HZ vaccine was introduced in China for the first time in 2020, and there is a lack of up-to-date information on the hospitalization costs a
n. s.: not significant; NIHSS: National Institutes of Health Stroke Scale; mean ± SD given; significance determined by t-test, Mann-Whitney, or chi2 test as appropriate.